2012年度このページを印刷する - 2012年度

  1. Kurahara Y, Kawaguchi T, Tachibana K, et al. Small-Cell Lung Cancer in Never Smokers: A Case Series with Information on Family History of Cancer and Environmental Tobacco Smoke. Clin Lung Cancer. 2012 Jan;13(1):75-9.

  2. Okishio K, Mio T, Kawahara M, et al. A Weekly Combination of Carboplatin and Irinotecan for Previously Untreated Extensive Disease Small-cell Lung Cancer, Results of a Minimum Follow-up of 3 Years: A Multi-center Phase II Trial JMTO LC02-02. Jpn J Clin Oncol. 2012;42:387-93.

  3. 吉田志緒美、露口一成、鈴木克洋ら. リファンピシン単独耐性結核菌の分子疫学的解析. Kekkaku 2012; 87(2): 41-45.
  4. Nakajima A, Nishiyama K, Morimoto M, et al. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience. Int J Radiat Oncol Biol Phys 2012;82:e129-35.
  5. Suzuki O, Nishiyama K, Morimoto M, et al. Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer. Jpn J Clin Oncol 2012;42:491-7.
  6. 佐々木由美子、藤本進、久保規彦ら：特発性間質性肺炎のおける6分間マイペース歩行試験の意義.　日呼ケアリハ学誌 2012；21:254-8.
  7. Gler MT, Skripconoka V, Sanchez-Garavito E, et al. Delamanid for Multidrug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2012;366:2151-60.
  8. Okada M, Kita Y, Nakajima T, et al. The study of novel DNA vaccines against tuberculosis: Induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis. Hum Vaccin Immunother. 2012; 9:pii:23229.
  9. T. Saito, S. Fujiuchi, Y. Tao, Y. Sasaki, K. Ogawa, K. Suzuki, A. Tada, M. Kuba, T. Kato, M. Kawabata, A. Kurashima, M. Sakatani. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan. Infection. 2012;40:661-7.
  10. Utsumi T, Sakamoto T, Sakaguchi M, et al. Preoperative identification of anomalous drainage vein for posterior segment of right upper lobe. Ann Thorac Surg. 2012; 94:e127.
  11. Kawaguchi T, Tamiya A, Tamura A, et al. Chemotherapy is beneficial forelderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70-74, 75-79, and 80 or older in Japan. Clin Lung Cancer.2012; 13:442-7.
  12. Atagi S, Kawahara M, Yokoyama A, et al. Japan Clinical Oncology Group Lung Cancer Study Group. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol. 2012; 13:671-8.
  13. Niho S, Ohe Y, Ishikura et al. Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402). Ann Oncol. 2012; 23:2253-8.
  14. Kawaguchi T, Takada M, Ando M, et al. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. Eur J Cancer. 2012; 48:672-7.
  15. 白石幸子、二見真史倉原優ら.　播種性血管内凝固を合併した粟粒結核にトロンボモジュリン製剤が奏効した1例. Kekkaku. 2012;87:771-6,
  16. Nishie K, Kawaguchi T, Tamiya A, et al. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations. J Thorac Oncol,2012; 7:1722-7.
  17. Tamiya M, Tamiya A, Nakao K, et al. Efficacy of carboplatin and paclitaxel with bevacizumab as salvage chemotherapy for non-small cell lung cancer after failure of platinum-doublet chemotherapy. Anticancer Res. 2012; 32:3553-7.
  18. Tamiya A, Naito T, Miura S, et al. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer. Anticancer Res. 2012 32:1103-6.
  19. Kurahara Y, Tachibana K, Kitaichi M, et al. Kikuchi-Fujimoto Disease Mimicking Tuberculous Lymphadenitis. Intern Med, 2012; 51:1927-30.
  20. Tachibana K, Arai T, Kagawa T, et al. A Case of Combined Sarcoidosis and Usual Interstitial Pneumonia. Intern Med. 2012; 51:1893-7.
  21. 金津正樹，井上義一，杉本親寿ら. 膠原病を伴うサルコイドーシスの3例 日本サルコイドーシス／肉芽腫性疾患学会雑誌　2012; 32:127-35.
  22. 蓑毛祥次郎，橘和延，北市正則ら. 肺結核の化学療法中に診断した肺Diffuse large B cell lymphoma（DLBCL）の一例. Kekkaku. 2012;87:663-667.
  23. 佐々木由美子，鈴木克洋，露口一成ら 過去10年間の当院における肺Mycobacterium szulgai症12例の臨床・細菌学的検討. Kekkaku. 2012;87:391-396.
  24. Okishio K, Mio T, Kawahara M, et al. A Weekly Combination of Carboplatin and Irinotecan for Previously Untreated Extensive Disease Small-cell Lung Cancer, Results of a Minimum Follow-up of 3 Years: A Multi-center Phase II Trial JMTO LC02-02. Jpn J Clin Oncol. 2012; 42:387-93.
  25. Kurahara Y, Tachibana K, Kitaichi M ,et al. Pulmonary Diffuse Alveolar Septal Amyloidosis. Intern Med, 2012; 51:1447-8.
  26. Kawaguchi T, Takada M, Okishio K, et al. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.2012;48:672-7.

  27. Tsujino K, Takeda Y, Arai T, et al. Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med. 2012 Jul 15;186:170-80.

  28. 杉本親寿, 井上義一．慢性呼吸不全の急性増悪．THE LUNG PERSPECTIVES. 2012;20:53-6.

  29. 井上義一. リンパ脈管筋腫症克服に向けて：患者とともに. 呼吸と循環. 2012;60:355-62.

  30. 吉田志緒美、富田元久、木原実香ら.結核菌群リファンピシン耐性遺伝子同定キット「ジェノスカラー・Rif TB」の実用性評価とリファンピシン耐性結核状況の推測. 日本臨床微生物学雑誌. 2012;22:42-8.

  31. 井上義一. リンパ脈筋腫症の新たな分子標的治療．日本サルコイドーシス/肉芽腫性疾患学会雑誌. 2012;32:89.

  32. 所昭宏、松田能宣、金津正樹ら. 肺がんの包括的アセスメントから検討するアプローチ. 緩和ケア. 2012;22:46-50.

  33. 井上義一. 特発性間質性肺炎診断と治療の手引き（改訂第2版）:改訂の経緯と概要. 呼吸と循環. 2013;61: 105-11.

  34. 佐々木由美子、鈴木克洋、露口一成ら. 過去10年間の当院における肺Mycobacterium szulgai症12例の臨床・細菌学的検討. 結核. 2012;391-6.

  35. 小橋保夫, 香川智子, 新井徹ら. 気腫合併肺線維症（CPFE）の今日的意義. 日本胸部臨床. 2012;71:1176-87.

  36. 竹内奈緒子, 井上義一. Birt-Hogg-Dubé 症候群. 呼吸器内科. 2012;22:83-9.

  37. 北市正則, 井上義一, 新井徹ら. 膠原病における間質性肺炎の病理像の特徴：特にUIP, NSIPを中心にして. 日本胸部臨床.2012;71:779-93.

  38. 鈴木克洋. 感染症－最近の動向と今後の課題－３）抗酸菌症. 日本内科学会雑誌. 2012; 101:2599-603.

  39. 鈴木克洋. 非結核性抗酸菌症の治療指針. Pharma Msdica.2012; 30:49-52.

  40. 露口 一成. 呼吸器内科:【呼吸器内科:EVIDENCE UPDATE】 結核と非結核性抗酸菌症.呼吸器内科. 2012;22:301-5.

ページトップへ